KIMBERLY ANDERSON: Open Payments
NPI 1184804767 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 45 payments from 9 companies in 2025. Trend: 2023 $57 · 2024 $417 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $206 |
| ABBVIE INC. | 13 | $185 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $184 |
| PFIZER INC. | 4 | $67 |
| SCILEX PHARMACEUTICALS INC. | 3 | $49 |
| Globus Medical, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $24 |
| Curonix LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: XTAMPZA, RELISTOR, UBRELVY, QULIPTA, NURTEC ODT, ZTLido, Senza, SARCLISA.
Industry payments across CA — which companies pay providers there.
